Search

Displaying results 4451 - 4460 of 6076 in total
  1. Drug

    SM-1997

    go.drugbank.com/drugs/DB18670
    Experimental

    [A261816] It is under investigation for the treatment of cutaneous sulfur mustard-induced injury.

  2. Drug

    Tulisokibart

    go.drugbank.com/drugs/DB18719
    Investigational

    It is being investigated for ulcerative colitis.

  3. Drug

    Olcegepant

    go.drugbank.com/drugs/DB04869
    Investigational

    Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks

  4. Drug

    R411

    go.drugbank.com/drugs/DB05468
    Experimental

    R411 is a non-steroid oral medicine for the treatment of asthma. It is not immunosuppressive, but blocks the activation and recruitment of cells involved in respiratory inflammation.

  5. Drug

    Piromidic acid

    go.drugbank.com/drugs/DB13744
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  6. Drug

    Tribenoside

    go.drugbank.com/drugs/DB13227
    Investigational

    Anti-inflammatory agent used in edema of extremities, varicose veins & phlebitis.

    Categories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
  7. Drug

    CER-001

    go.drugbank.com/drugs/DB18538
    Investigational

    [L48290] It is under investigation for the treatment of lecithin-cholesterol acyltransferase (LCAT) deficiencies.

  8. Drug

    Safimaltib

    go.drugbank.com/drugs/DB21528
    Investigational

    Safimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).

  9. Drug

    Vonlerolizumab

    go.drugbank.com/drugs/DB16352
    Investigational

    trial NCT03029832 (A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for

  10. Drug

    ZB131

    go.drugbank.com/drugs/DB17164
    Investigational

    ZB131 is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin (CSP), a cell surface protein identified in a wide range of cancers that correlates with poor prognosis and